Respiratory disease Flashcards
Typical characteristics of COPD
Smoker/exsmoker, rarely symptoms before 35y, common with chronic productive cough, persisten/progressive breathlessness. Uncommon with waking up at night or significant diurnal variability. FEV ad FEV/FVC ration never return to normal with drug therapy.
Typical characteristics of bronchial asthma
Possibly a smoker. Commonly onset < 35y. Uncommon w chronic productive cough. Breathlessness is varible. Common w waking up at night and significant diurnal variability. Probably return of Fev, FEV/FVC ratio after drug tx
What are the risk factors of COPD
- Smoking 2. Occupation ( organic, inorganic dust, chemical agent, fumes) 3. Pollution (smoke. pipe, water pipe) 4. Genes, deficiency of alpha 1 antitrypsin. 5. Low birth weight, resp. inf. 6. Asthma 7. Aging and female gender 8. Socioeconomic status (poor nutrition, infectious air, pollutants)
What will spirometry show in COPD
Post- bronchodilator FEV1/FVC <0,70
What is the definition of COPD
A common preventable and treatable disease, is characterized by persistent resp sx and airflow limitation that is due to airway and or alveolar abnormalities usually caused by significant exposure to noxious particles and gases.
What are the sx of COPD
- Dyspnea: progressive over time, worse w exercise, persistent
- Chronic cough ( often the first symptom) w sputum production
What do you have to think about when interviewing a COPD pat?
NB! The symptoms may be under-reported!
Dx of COPD
- Sx + risk + spirometry
- spirometry is required to establish dx, post bronchodilator FEV1/FVC < 0,7 confirms the presence of airflow limitation
How can you assess a COPD pat?
- Modified medical research council dyspnea scale (mMRC) = dyspnea in rest and activity
- COPD assessment test (CAT) = impact on life and changes over time
- More than or at 2 /1 are leading to hospital admission
What increase the risk of exacerbations in COPD?
- Increasing airflow limitation increase risk
- Comorbidities: cardiovascular disease, osteoporosis, depression and anxiety, skeletal muscle dysfunction, metabolic sd, lung cancer
What are the main goals of treatment in COPD?
- Sx: Relieve sx, improve exercise tolerance, improve health status
- Risk: Prevent disease progression, prevent and treat exacerbations and reduce mortality
Treatment of category A COPD
- Bronchodilator
- Continue, stop or try alternative class of bronchodilator
Tx of cat B COPD
- Long acting bronchodilator (LABA or LAMA)
- LAMA + LABA if persistent sx
Tx of cat C COPD
- LAMA
- LAMA + LABA if further exacerbation
- LAMA + ICS (inhaled corticosteroids)
Tx of cat D COPD
- LAMA
- LAMA + LABA
- LABA + ICS
- LAMA + LABA + ICS
- Consider macrolide
- Consider roflumitest if FEV1 < 50% and pat has chronic bronchitis
How is non-pharmacologic mx of COPD
A. 1) Smoking cessation 2) Physical activity 3) flu vaccine, pneumococcal vaccine
BCD. Same + pulmonary rehabilitation
What is the NB! of COPD?
- Often coexist w other disease that may have a significant impact on disease course. They should be treated per usual standard regardless of the presence of COPD
- Comorbidities are often under diagnosed and are ass w poor health status and Px.
- Ensure simplicity of treatment and to minimize polypharmacy